Raymond James & Associates »

Dyne Therapeutics shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.8M 169k 28.39
2023-12-31 $1.2M 87k 13.30
2023-09-30 $791k 88k 8.96
2023-06-30 $810k 72k 11.25
2023-03-31 $889k 77k 11.52
2022-12-31 $642k 55k 11.59
2022-09-30 $739k 58k 12.70